logo
Top 5 Dividend ETFs For 2025

Top 5 Dividend ETFs For 2025

Globe and Mail4 days ago
Want expert insights on REITs and BDCs? Join Colorado Wealth Management Fund's email list—widely regarded as the top REIT analyst on Seeking Alpha. Stay ahead of the market with exclusive updates! [ Sign Up Now ]
These five dividend ETFs continue to offer low expense ratios, solid sector diversification, and reliable dividend income in 2025.
For investors looking to build a durable equity income portfolio, these ETFs remain among the top choices. While they still leave out a few useful sectors (real estate, utilities), they make a strong starting point for long-term investors who want their portfolio to actually pay them.
SCHD: Still a Favorite for Quality and Yield
The Schwab U.S. Dividend Equity ETF (SCHD) remains one of the most popular dividend ETFs for good reason. With an expense ratio of just 0.06%, it provides exposure to high-quality U.S. companies with consistent dividend histories. SCHD leans heavily into consumer staples and industrials, while underweighting financials and avoiding real estate altogether.
It's a great core holding for long-term investors, but those building a more balanced portfolio may want to add complementary exposure to sectors SCHD leaves out - like real estate, utilities, or floating-rate preferred shares.
VYM: The Classic High-Yield Workhorse
The Vanguard High Dividend Yield ETF (VYM) continues to be a strong option for income-focused investors. Also carrying a rock-bottom 0.06% expense ratio, VYM holds over 400 U.S. stocks with above-average dividend yields. It includes solid exposure to financials and energy - two sectors often underrepresented in other dividend-focused funds.
VYM doesn't try to outsmart the market - it focuses on companies that actually pay. That's why it remains one of the most consistent picks in the dividend ETF space. It also makes a great pairing with SCHD for those who want both quality and yield in their portfolio.
VIG: For Dividend Growth Enthusiasts
The Vanguard Dividend Appreciation ETF (VIG) doesn't chase yield - it focuses on companies with a long history of increasing dividends. With a 0.06% expense ratio, VIG offers exposure to companies that tend to be more stable and less cyclical, but also leans heavily into the industrials sector.
VIG skips real estate and carries minimal energy exposure, so it may not be ideal as a standalone holding. However, for investors looking to prioritize long-term dividend growth over raw yield, it makes a lot of sense - especially when paired with something more income-oriented like HDV or SCHD.
DGRO: Balanced, Understated, Effective
The iShares Core Dividend Growth ETF (DGRO) is often overlooked but deserves more attention. It blends dividend growth with moderate yield and includes meaningful exposure to financials and tech. The fund charges a slightly higher expense ratio of 0.08%, but it makes up for it with a well-diversified portfolio that avoids major concentration risk.
DGRO doesn't swing for the fences, but it rarely strikes out either. For investors who want a middle-of-the-road fund that complements either high-yield or high-growth ETFs, DGRO is a great pick in 2025.
HDV: High-Yield Defense When You Need It
The iShares Core High Dividend ETF (HDV) is the most defensive option on this list. It focuses on companies with stable earnings and high dividend yields, and tends to lean into sectors like healthcare and consumer staples. Its expense ratio is 0.08%, and its yield remains one of the highest among the big-name dividend ETFs.
HDV tends to underweight financials and avoids energy and real estate. That makes it a bit less well-rounded, but great for income investors who want lower beta and a strong defensive tilt.
One Glaring Omission: Real Estate (Again)
As with previous years, none of these five ETFs offers meaningful exposure to real estate. That's a recurring blind spot - and an easy one to fix. Investors can add a fund like the Vanguard Real Estate ETF (VNQ) or choose from individual REITs like (O), (NNN), or (WPC) to round out the portfolio. The yield from quality REITs also pairs well with the more defensive holdings in this group.
It's important to note that we easily beat our benchmark from inception. That includes our choices or REITS, mREITS, BDCs, and preferred shares.
Bonus Pick: Want Tech Exposure Without Giving Up Your Dignity?
While none of the five ETFs above offer real exposure to big-name tech stocks, investors who want to stay connected to the modern economy can consider the Vanguard Information Technology ETF (VGT). It's not a dividend fund, but it includes (AAPL), (MSFT), (NVDA), (TSLA), and other heavyweights at a low cost (0.10% expense ratio).
Adding VGT won't do a lot to boost your income via dividends, but it can add some long-term capital appreciation while helping you keep up with what the kids are doing.
Final Thoughts
The five core dividend ETFs - SCHD, VYM, VIG, DGRO, and HDV - continue to provide excellent foundations for income-oriented portfolios in 2025. They've stood the test of time with low fees, strong management, and reliable performance.
You'll still need to plug a few holes (real estate, utilities, maybe preferred shares), but you're starting with a very solid base.
Now go get your dividends.
Join The REIT Forum by Colorado Wealth Management Fund, trusted by over 60,000 investors for expert analysis on REITs, BDCs, and preferred shares.
This article was compiled by my assistant. If there are any mistakes, blame him - I certainly will.
Disclosure: I currently have a position in O . I may frequently trade in the preferred shares of any mortgage REIT and occasionally in the common shares.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's tariff threats against Canada face legal hurdles ahead of August deadline
Trump's tariff threats against Canada face legal hurdles ahead of August deadline

National Post

time2 minutes ago

  • National Post

Trump's tariff threats against Canada face legal hurdles ahead of August deadline

Donald Trump's plan to realign global trade faces its latest legal barrier this week in a federal appeals court — and Canada is bracing for the U.S. president to follow through on his threat to impose higher tariffs. Article content While Trump set an Aug. 1 deadline for countries to make trade deals with the United States, the president's ultimatum has so far resulted in only a handful of frameworks for trade agreements. Article content Article content Article content Deals have been announced for Japan, Vietnam, Indonesia, the Philippines and the United Kingdom — but Trump indicated last week that an agreement with Canada is far from complete. Article content Trump sent a letter to Prime Minister Mark Carney threatening to impose 35 per cent tariffs if Canada doesn't make a trade deal by the deadline. The White House has said those duties would not apply to goods compliant with the Canada-U.S.-Mexico Agreement on trade. Article content Article content Countries around the world will also be watching as Trump's use of a national security statute to hit nations with tariffs faces scrutiny in the United States Court of Appeals for the Federal Circuit. Article content The U.S. Court of International Trade ruled in May that Trump does not have the authority to wield tariffs on nearly every country through the use of the International Economic Emergency Powers Act of 1977. Article content The act, usually referred to by the acronym IEEPA, gives the U.S. president authority to control economic transactions after declaring an emergency. No previous president had ever used it for tariffs and the U.S. Constitution gives power over taxes and tariffs to Congress. Article content Article content The Trump administration quickly appealed the lower court's ruling on the so-called 'Liberation Day' and fentanyl-related tariffs and arguments are set to be heard in the appeal court on Thursday. Article content George Mason University law professor Ilya Somin called Trump's tariff actions a 'massive power grab.' Somin, along with the Liberty Justice Center, is representing the American small businesses.

U.S. says tariff deadline of Aug 1 is firm, no extensions
U.S. says tariff deadline of Aug 1 is firm, no extensions

CTV News

time39 minutes ago

  • CTV News

U.S. says tariff deadline of Aug 1 is firm, no extensions

U.S. President Donald Trump listens to members of the media after he arrived at Prestwick Airport in Ayrshire, Scotland, Friday, July 25, 2025.(AP Photo/Jacquelyn Martin) WASHINGTON — The U.S. deadline of August 1 for imposing tariffs on its trading partners is firm and there will be no extensions, U.S. Commerce Secretary Howard Lutnick said Sunday. 'So no extensions, no more grace periods. August 1, the tariffs are set. They'll go into place. Customs will start collecting the money, and off we go,' Lutnick told 'Fox News Sunday.' After the levies kick in, U.S. President Donald Trump -- who was negotiating Sunday in Scotland with European Union officials -- is still willing to keep talking, Lutnick said. Of the Europeans, Lutnick said, 'You know they're hoping they make a deal, and it's up to President Trump, who's the leader of this negotiating table. We set the table.' So far five countries have struck deals with the Trump administration ahead of the Friday deadline as it tries to overhaul the global system of largely free trade by slapping tariffs on countries that the United States deems as engaging in unfair practices. These five are Britain, Vietnam, Indonesia the Philippines, and Japan. The levies they accepted are often higher than the new base rate of 10 percent that the United States has applied to most countries since April. But they are far below the levels the Trump administration threatened to impose if no deal were reached. AFP

Codex Labs to Exhibit at The Society for Pediatric Dermatology's 50th Annual Meeting
Codex Labs to Exhibit at The Society for Pediatric Dermatology's 50th Annual Meeting

Globe and Mail

timean hour ago

  • Globe and Mail

Codex Labs to Exhibit at The Society for Pediatric Dermatology's 50th Annual Meeting

Seattle, Wash. - July 22nd, 2025 - Codex Labs, a biotech skincare company focused on microbiome-friendly solutions, is honored to participate in The Society for Pediatric Dermatology's (SPD) 50th Annual Meeting. Taking place from July 23rd to 26th at The Westin Seattle, the event will celebrate five decades of advancing pediatric dermatology through education, research, and collaboration. "Codex Labs is delighted to be attending The Society for Pediatric Dermatology's 50th Annual Meeting and presenting a novel plant-based biotech eczema lotion and cleanser for children as young as 3 weeks old,' says founder and CEO Dr. Barbara Paldus. 'We believe that these new topicals, when combined and targeted with pre- and probiotics, will usher in a future of highly effective, steroid-free alternatives for the management of pediatric atopic dermatitis." The SPD comprises over 1,800 members worldwide, including pediatricians, dermatologists, pediatric dermatologists, and other healthcare professionals. At this year's milestone 50th SPD Annual Meeting, Codex Labs will be one of many organizations gathering to support the advancement of pediatric dermatology. The SPD's 50th Annual Meeting will take place over four days and feature networking opportunities, support group discussions, lecture sessions, companies and exhibitors showcasing their products, and organizations dedicated to pediatric dermatology research and advancement. Some key topics highlighted at this year's meeting include infections, medications and therapies, psoriasis and inflammatory skin conditions, tumors and neoplasms, vascular lesions, and more. Codex Labs will be attending this year's 50th Annual Meeting and sponsoring the Early Career Networking Reception on Wednesday, July 23rd at 6:00 pm. This event is for medical doctors completing a fellowship or those out of training for five years or less, where they can share experiences and connect with other young dermatologists. Dr. Jessica Maloh, Naturopathic Doctor and Head of Naturopathic Medicine at Codex Labs, will be attending the event and presenting a research poster that highlights the use of oral probiotics as adjunctive interventions for acne. 'Acne is one of the most common skin conditions affecting adolescents, often impacting not only the skin, but also self-esteem and quality of life,' says Dr. Maloh. 'At the SPD, I'm excited to share a summary of the research on the adjunctive use of oral probiotics in acne management- an intervention that may complement conventional dermatologic treatments like antibiotics and oral isotretinoin. Integrative strategies like this have been found to enhance acne treatment efficacy while also supporting the gut microbiome.' Codex Labs is honored to participate in the 50th Annual Meeting and looks forward to showcasing its products and findings. Dr. Maloh invites guests to the Networking Reception and to visit her team's presentation to learn more about their skincare breakthroughs and the latest in integrative dermatology research. Event Details: Location: The Westin Seattle, located at 1900 5th Ave, Seattle, WA 98101. For more information about Codex Labs and its products, please visit If you are interested in learning more about Codex Labs' participation in The SPD's 50th Annual Meeting, please contact About Codex Labs: Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Codex Labs' products focus on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema, and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free, and sustainable plant-based solutions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store